Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by toolmantayloron Dec 07, 2016 3:39am
232 Views
Post# 25564353

I am not big on technicals

I am not big on technicalsI disagree, I am thinking that the amount of good news and recent decline in share price will make it one hell of a struggle to go below $2.00. This "Hump Day" and until the debentures are released are when we can expect some degree of throttling back on shorts. If I did have a short position myself I would sell a bit before the debentures are fair to trade. We all know and seem to agree this company will have a higher share price soon, so I think the debentures will be held until over $3.00.  

         It would be good to know that the stipulations of the agreement depended on the share price holding $3.00 for 10 days for forced conversion, OR else they could convert at any price second week of december. They managed to get the deal where they can convert at any price. It is safe to assume they will hold and be selling off in the next few months. Their not selling off immediately and knowledge of the agreement , could cause a spike a bit before the day they can begin selling. The selling could instead happen years for now. Who really knows, but again, almost everyone agrees that Aurora will be successful in the coming year.


Tradingvet55 wrote: Expecting to see this open around 2.04-2.06. Cgc will gap down resulting in most other mj plays following suit. Get ready to test $2 early on tomorrow morning and then the next test to 1.80. The chart is screaming sell right now as the bearish trend continues due to lack of any significant catalysts and heavy dilution starting next week (54 million shares of debentures) . Also the news going around of acb being sued and having to give up an additional 9 million shares of dilution in the lawsuit slated for Feb or March 2017 is just killing buyer sentiment here. This week should see some mid 1s so be ready to scoop anything in the 1.50s starting this week and alot more next week when the dilution begins.

Bullboard Posts